Award
Delivery Order #15B10927F00000014
McKesson Awarded Delivery Order for Controlled Medications in MAT Therapy
Buyer
Federal Prison System / Bureau of Prisons
Award Amount
$19,336.50
Ceiling
$19,336.50
Awarded
October 01, 2026
Period of Performance
Oct 01, 2026 – Oct 31, 2026
Identifier
15B10927F00000014
NAICS
325412
This award is a delivery order contract under the Pharmaceutical Prime Vendor Contract (PPV) indefinite delivery vehicle held by McKesson Corporation. The contract focuses on the procurement of controlled and non-controlled medications specifically for inmate use in opioid use disorder treatment through medication-assisted therapy (MAT). McKesson, a leading healthcare supply chain company, provides pharmaceutical products to government agencies, facilitating improved treatment options for vulnerable populations. The contract supports the Department of Veterans Affairs by ensuring the availability of essential medications within correctional healthcare settings, contributing to public health and safety. The work scope includes multiple invoices of specified medications over a one-month period, reflecting ongoing supply continuity within the fiscal year. This delivery order stems from a multi-billion dollar prime vendor contract awarded competitively, reinforcing McKesson's role as a key pharmaceutical provider. The award was effective starting October 1, 2026, and covers a defined performance span of one month.
Description
MCKESSON CONTRACT - ACCT 677508 - CONTROLLED AND NON-CONTROLLED MEDICATION PURCHASE FOR INMATE USE FOR OPIOID USE DISORDER TREATMENT (MAT THERAPY) - 90F MEDICATIONS/ 1060ADB -- MULTIPLE INVOICES PURCHASED FOR FY27 1-31 OCT